Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Two Scientists Receive Grants for ‘Unconventional’ Research

David Sretavan
David Sretavan

Two UCSF researchers are among the first-ever recipients of $42.2 million in federal grants supporting projects that take scientific risks, but also offer potentially huge rewards.

Print story

E-mail story

David Sretavan, MD, PhD, a UCSF professor of ophthalmology and physiology, and John Sedat, PhD, a UCSF professor of biochemistry and biophysics, were selected, along with 36 other researchers from around the country, as part of the new Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) program of the National Institutes of Health (NIH).

Two Scientists Receive Grants for ‘Unconventional’ Research

SAN FRANCISCO, CA | Posted on September 23rd, 2008

According to the NIH, the program "targets investigators who are testing novel, unconventional hypotheses or are pursuing major methodological or technical challenges." The projects selected for funding must be "substantial in terms of both the size of the scientific community affected and the magnitude of [their] impact on the community," the NIH said on its website.

"EUREKA projects promise remarkable outcomes that could revolutionize science," said NIH Director Elias A. Zerhouni, MD. "The program reflects NIH's commitment to supporting potentially transformative research, even if it carries a greater than usual degree of scientific risk."

"Transform" is exactly what Sretavan hopes to do in the field of nerve injury treatment. Up to now, attempts to promote regrowth in damaged human nerve cells have not translated into successful clinical procedures.

Sretavan's idea: Splice individual nerve cells back together, using the rapidly advancing sciences of micro- and nanotechnology. He envisions a future where special "cellular surgical devices" are used to repair individual nerve cells in people with devastating neurological disorders. Such technologies are only just beginning to be used in biology and medicine, Sretavan said, calling his team's research a "radical departure from existing approaches."

"This is a whole new area of medical research and clinical medicine," he said. "It's kind of an interesting challenge because it requires us to collaborate with a lot of people who haven't really thought about their research being used in biology. It's teamwork, but teamwork with people who almost speak a different scientific language."

With the EUREKA grant money behind them, Sretavan and his team will now focus their efforts on proving that once nerve cells are joined back together, they function the way they are supposed to.

"If you can't demonstrate that, then it would go a long way to convincing others to think about and try this approach," he said.

Like Sretavan, UCSF's Sedat is also hoping to explore the biological applications of emerging technologies. His research focuses on the use of adaptive optics to reduce distortion and produce high-resolution images from deep inside living tissue. Sedat was out of the country and could not be interviewed for this article.

Sretavan, Sedat and other grant recipients will receive up to $200,000 per year for four years to fund their projects - a welcome boost in a weak economy and the current research funding environment.

"These are very tough research funding times," Sretavan said. "And what's great about this EUREKA program is that it shows that the NIH is continually trying to identify and support new ideas, even when, as an institution, it is under substantial budgetary pressure."


For more information, please click here

Copyright © UCSF

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014


NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014


Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

QD Vision Wins Prestigious Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency October 16th, 2014

Beyond LEDs: Brighter, new energy-saving flat panel lights based on carbon nanotubes - Planar light source using a phosphor screen with highly crystalline single-walled carbon nanotubes (SWCNTs) as field emitters demonstrates its potential for energy-efficient lighting device October 14th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE